Redox-dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice

Hepatology

Volumn 65, Issue 1, 2017, Pages 253-268

  Sun, Qian ^a   Loughran, Patricia ^a,b   Shapiro, Richard ^a   Shrivastava, Indira H ^c   Antoine, Daniel J ^d   Li, Tunliang ^a,e   Yan, Zhengzheng ^a   Fan, Jie ^a,f   Billiar, Timothy R ^a   Scott, Melanie J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^f Veteran Affairs Pittsburgh Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENT IN MELANOMA 2 PROTEIN; ALANINE AMINOTRANSFERASE; CELL NUCLEUS DNA; CRYOPYRIN; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOCHONDRIAL DNA; PARACETAMOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AIM2 PROTEIN, MOUSE; DNA BINDING PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BINDING AFFINITY; CELL DEATH; CELL HYPOXIA; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; EXPERIMENTAL HEMORRHAGIC SHOCK; EXPERIMENTAL LIVER INJURY; INTRACELLULAR SIGNALING; LIVER CELL; LIVER PROTECTION; MALE; MOLECULAR DOCKING; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; REDOX STRESS; REOXYGENATION; ANIMAL; C57BL MOUSE; LIVER DISEASES; METABOLISM; PHYSIOLOGY;

ANIMALS; CASPASE 1; DNA-BINDING PROTEINS; HEPATOCYTES; HMGB1 PROTEIN; INFLAMMASOMES; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION;

EID: 85007226842     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28893     Document Type: Article

References (43)

1. Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, et al. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest 2016;126:859-864.
2. McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 2012;122:1574-1583.
3. Marques PE, Oliveira AG, Pereira RV, David BA, Gomides LF, Saraiva AM, et al. Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice. Hepatology 2015;61:348-360.
4. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009;119:305-314.
5. Atianand MK, Fitzgerald KA. Molecular basis of DNA recognition in the immune system. J Immunol 2013;190:1911-1918.
6. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, et al. Activation of autophagy by inflammatory signals limits IL-1 beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012;13:255-263.
7. Harberts E, Gaspari AA. TLR signaling and DNA repair: are they associated? J Invest Dermatol 2013;133:296-302.
8. Yazdi AS, Drexler SK, Tschopp J. The role of the inflammasome in nonmyeloid cells. J Clin Immunol 2010;30:623-627.
9. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010;10:826-837.
10. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458:509-513.
11. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012;36:401-414.
12. Yanai H, Ban T, Wang ZC, Choi MK, Kawamura T, Negishi H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009;462:99-103.
13. Tang D, Kang R, Van Houten B, Zeh HJ, Billiar TR, Lotze MT. High-mobility group box 1 (HMGB1) phenotypic role revealed with stress. Mol Med 2014;20:359-362.
14. Tang D, Billiar TR, Lotze MT. A Janus tale of two active high-mobility group box 1 (HMGB1) redox states. Mol Med 2012;18:1360-1362.
15. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010;190:881-892.
16. Huebener P, Gwak GY, Pradere JP, Quinzii CM, Friedman R, Lin CS, et al. High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab 2014;19:539-547.
17. Tang D, Loze MT, Zeh HJ, Kang R. The redox protein HMGB1 regulates cell death and survival in cancer treatment. Autophagy 2010;6:1181-1183.
18. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011;54:133-144.
19. Sun Q, Gao W, Loughran P, Shapiro R, Fan J, Billiar TR, et al. Caspase-1 activation is protective against hepatocyte cell death by up-regulating beclin1 protein and mitochondrial autophagy in the setting of redox stress. J Biol Chem 2013;288:15947-15958.
20. Hierholzer C, Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001;386:302-308.
21. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med 2010;48:1121-1132.
22. Li J, Wang H, Mason JM, Levine J, Yu M, Ulloa L, et al. Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 2004;289:211-223.
23. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
24. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 2004;39:1533-1543.
25. Santos JH, Meyer JN, Mandavilli BS, Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol 2006;314:183-199.
26. Bauer EM, Shapiro R, Billiar TR, Bauer PM. High mobility group box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4 and interferon response factor 3–dependent mechanism(s). J Biol Chem 2013;288:1365-1373.
27. Huang H, Nace GW, McDonald KA, Tai S, Klune JR, Rosborough BR, et al. Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection. Hepatology 2014;59:1984-1997.
28. Prince JM, Ming MJ, Levy RM, Liu S, Pinsky DJ, Vodovotz Y, et al. Early growth response-1 mediates the systemic and hepatic inflammatory response initiated by hemorrhagic shock. Shock 2007;27:157-164.
29. Ge X, Antoine DJ, Lu Y, Arriazu E, Leung TM, Klepper AL, et al. High-mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem 2014;289:22672-22691.
30. Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, et al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest 2015;125:539-550.
31. Lagoa CE, Vodovotz Y, Stolz DB, Lhuillier F, McCloskey C, Gallo D, et al. The role of hepatic type-1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 2005;42:390-399.
32. Menzel CL, Sun Q, Loughran PA, Pape HC, Billiar TR, Scott MJ. Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med 2011;17:1031-1038.
33. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor-4-dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007;204:2913-2923.
34. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222-230.
35. Jin T, Perry A, Jiang J, Smith P, Curry JA, Unterholzner L, et al. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2-inflammasome and IFI16 receptor. Immunity 2012;36:561-571.
36. Kozakov D, Brenke R, Comeau SR, Vajda S. PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 2006;65:392-406.
37. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004;20:45-50.
38. Grove LE, Hall DR, Beglov D, Vajda S, Kozakov D. FTFlex: accounting for binding site flexibility to improve fragment-based identification of druggable hot spots. Bioinformatics 2013;29:1218-1219.
39. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012;209:1519-1528.
40. Kaczorowski DJ, Scott MJ, Pibris JP, Afrazi A, Nakao A, Edmonds RD, et al. Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B. Mol Med 2012;18:851-860.
41. Liu L, Yang M, Kang R, Dai Y, Yu Y, Gao F, et al. HMGB1-DNA complex-induced autophagy limits AIM2 inflammasome activation through RAGE. Biochem Biophys Res Commun 2014;450:851-856.
42. Jin T, Perry A, Smith P, Jiang J, Xiao TS. Structure of the absent in melanoma-2 (AIM2) pyrin domain provides insights into the mechanisms of AIM2 autoinhibition and inflammasome assembly. J Biol Chem 2013;288:13225-13235.
43. Wilson JE, Petrucelli AS, Chen L, Koblansky AA, Truax AD, Oyama Y, et al. Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt. Nat Med 2015;21:906-913.